Evonik stock reports November 3 results, slightly higher pre-market
Published on 10/26/2026 at 07:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSQuarterly report scheduled
- Evonik has scheduled its third-quarter 2026 report for November 3, 2026.
- The reference trading session ended on October 23, 2026.
- Evonik stock trades pre-market at EUR 21.38 at 7:37 a.m. CET at Lang & Schwarz on October 26, 2026, 0.56 percent above the Xetra close of October 23, 2026.
Evonik's investor-relations calendar lists the company's third-quarter 2026 report for November 3, 2026, according to Evonik's investor-relations site. Evonik stock trades pre-market at EUR 21.38 at 7:37 a.m. CET at Lang & Schwarz on October 26, 2026, 0.56 percent above the Xetra close of October 23, 2026 (EUR 21.26).
Evonik's reporting calendar
The scheduled report covers the third quarter of 2026 and is due on November 3, 2026. The date is listed in the company's investor-relations calendar.
Pre-market indication
The stock is EUR 0.12 above the reference close. The further course from the Xetra open at 9:00 a.m. CET is shown by the continuously updated real-time quote of Evonik stock.
The group's business markets
Evonik operates in specialty chemicals, supplying materials and compounds for industrial, consumer, animal nutrition and healthcare applications. Market context: Market report DAX.
